Daqinjiao Decoction Ameliorates CSVD via RXR‐γ/PPAR‐γ/VEGF‐α Pathway: Insights From Transcriptome Sequencing and Network Pharmacology
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70712 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Mengna Lv und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Vascular Endothelial Growth Factor A, PPAR gamma, Transcriptome. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Fundamental Research Funds for the Central Public Welfare Research Institutes, Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences.
Abstract (Originalsprache)
Daqinjiao decoction (DQJD), an ancient traditional Chinese medicine formula, is clinically used in the treatment of cerebral small vessel disease (CSVD). However, the underlying molecular mechanisms by which DQJD exerts its therapeutic effects on CSVD remain elusive. A Sprague Dawley rat model of chronic cerebral hypoperfusion (CCH) was established using bilateral common carotid artery occlusion (BCCAO) surgery. The effects of DQJD administered via intragastric gavage (i.g.) were evaluated by magnetic resonance imaging (MRI), haematoxylin eosin (HE) staining, and transmission electron microscopy. A combined strategy of transcriptomics and network pharmacology was innovatively applied to study the active ingredients, gene targets, and mechanisms of DQJD in treating CSVD. Molecular docking, real‐time quantitative polymerase chain reaction (RT‐qPCR), and Western blot analysis were applied to confirm the above results further. DQJD improved the pathological damage in cortical and hippocampal tissue by reducing the release of inflammatory factors in CCH rats. RNA‐seq technology identified 46 DEGs between DQJD treatment and the model group. Network pharmacology and pathway analysis of DEGs revealed that the PPAR/VEGF signalling pathway was predicted to be significantly affected. Consistently, validation experiments confirmed that activation of the RXR‐γ/PPAR‐γ/VEGF‐α signalling pathway represents a key mechanism underlying DQJD's therapeutic effects against CSVD. DQJD dampened inflammation and ameliorated pathological damage in the hippocampus and cortex, and these beneficial effects were associated with neurovascular protection via activating the RXR‐γ/PPAR‐γ/VEGF‐α pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Experimental Research Center, Beijing Key Laboratory of Research of Chinese Medicine on Prevention and Treatment for Major Diseases, China Academy of Chinese Medical Sciences, Beijing, China.
- Central Laboratory, Baoshan District Hospital of Integrated Traditional Chinese and Western Medicine of Shanghai, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
ORCID-Profile: Wenjie Li, Mingmei Zhou
Förderung
- The Fundamental Research Funds for the Central Public Welfare Research Institutes
- Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences
Zitieren
APA
Lv, M., Yang, X., Shi, X., Cao, S., Li, W., Zhou, M., Gou, X., & Huang, Y. (2025). Daqinjiao Decoction Ameliorates CSVD via RXR‐γ/PPAR‐γ/VEGF‐α Pathway: Insights From Transcriptome Sequencing and Network Pharmacology. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70712
Vancouver
Lv M, Yang X, Shi X, Cao S, Li W, Zhou M, et al. Daqinjiao Decoction Ameliorates CSVD via RXR‐γ/PPAR‐γ/VEGF‐α Pathway: Insights From Transcriptome Sequencing and Network Pharmacology. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70712
BibTeX
@article{Lv2025,
author = {Lv, Mengna and Yang, Xiaolu and Shi, Xiaolu and Cao, Shengxuan and Li, Wenjie and Zhou, Mingmei and Gou, Xiaojun and Huang, Ying},
title = {Daqinjiao Decoction Ameliorates CSVD via RXR‐γ/PPAR‐γ/VEGF‐α Pathway: Insights From Transcriptome Sequencing and Network Pharmacology},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70712}
}
EUVIMED